Private equity firm ChrysCapital-backed Ipca Laboratories Ltd on Wednesday announced that it has acquired an 80 per cent stake in New Jersey-based Bayshore Pharmaceuticals LLC for a cash consideration of $10.28 million.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
